Compare AANJANEYA LIFECARE with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs LUPIN - Comparison Results

LUPIN 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS LUPIN DR. DATSONS LABS/
LUPIN
 
P/E (TTM) x -10.9 107.9 - View Chart
P/BV x 0.2 2.5 6.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   LUPIN
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
LUPIN
Mar-19
DR. DATSONS LABS/
LUPIN
5-Yr Chart
Click to enlarge
High Rs126986 12.7%   
Low Rs31720 4.3%   
Sales per share (Unadj.) Rs133.0369.5 36.0%  
Earnings per share (Unadj.) Rs0.213.4 1.1%  
Cash flow per share (Unadj.) Rs6.637.4 17.7%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.8303.7 42.4%  
Shares outstanding (eoy) m31.66452.49 7.0%   
Bonus/Rights/Conversions FCCBESOP-  
Price / Sales ratio x0.62.3 25.5%   
Avg P/E ratio x516.163.6 810.9%  
P/CF ratio (eoy) x11.822.8 51.9%  
Price / Book Value ratio x0.62.8 21.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,477386,064 0.6%   
No. of employees `000NA17.7 0.0%   
Total wages/salary Rs m5631,513 0.2%   
Avg. sales/employee Rs ThNM9,453.8-  
Avg. wages/employee Rs ThNM1,782.0-  
Avg. net profit/employee Rs ThNM343.0-  
INCOME DATA
Net Sales Rs m4,211167,182 2.5%  
Other income Rs m793,640 2.2%   
Total revenues Rs m4,289170,822 2.5%   
Gross profit Rs m56928,822 2.0%  
Depreciation Rs m20410,850 1.9%   
Interest Rs m4303,078 14.0%   
Profit before tax Rs m1318,534 0.1%   
Minority Interest Rs m0-89 0.0%   
Prior Period Items Rs m-238 -4.8%   
Extraordinary Inc (Exp) Rs m0-3,400 0.0%   
Tax Rs m69,017 0.1%   
Profit after tax Rs m56,066 0.1%  
Gross profit margin %13.517.2 78.3%  
Effective tax rate %48.048.7 98.7%   
Net profit margin %0.13.6 3.1%  
BALANCE SHEET DATA
Current assets Rs m6,852138,536 4.9%   
Current liabilities Rs m6,71161,299 10.9%   
Net working cap to sales %3.346.2 7.2%  
Current ratio x1.02.3 45.2%  
Inventory Days Days16184 192.0%  
Debtors Days Days318112 283.3%  
Net fixed assets Rs m3,673127,516 2.9%   
Share capital Rs m317905 35.0%   
"Free" reserves Rs m3,761136,517 2.8%   
Net worth Rs m4,078137,422 3.0%   
Long term debt Rs m1,67166,417 2.5%   
Total assets Rs m12,633279,494 4.5%  
Interest coverage x1.07.0 14.7%   
Debt to equity ratio x0.40.5 84.8%  
Sales to assets ratio x0.30.6 55.7%   
Return on assets %3.43.3 105.3%  
Return on equity %0.14.4 2.7%  
Return on capital %7.78.9 86.1%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96459,414 1.6%   
Fx outflow Rs m60722,282 2.7%   
Net fx Rs m35737,132 1.0%   
CASH FLOW
From Operations Rs m1,34516,660 8.1%  
From Investments Rs m-2,256-32,825 6.9%  
From Financial Activity Rs m-1,2007,441 -16.1%  
Net Cashflow Rs m-2,111-8,724 24.2%  

Share Holding

Indian Promoters % 4.5 46.6 9.7%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 0.0 11.3 -  
FIIs % 1.4 31.9 4.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 10.1 931.7%  
Shareholders   20,807 98,259 21.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ORCHID PHARMA LTD  CIPLA  ABBOTT INDIA  SUVEN LIFESCIENCES  WYETH LTD  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Marginally Up; Telecom Stocks Rally(09:30 am)

Asian share markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.6% while the Hang Seng is up 0.9%.

Related Views on News

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS